152 related articles for article (PubMed ID: 9695994)
1. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins.
Terjung B; Herzog V; Worman HJ; Gestmann I; Bauer C; Sauerbruch T; Spengler U
Hepatology; 1998 Aug; 28(2):332-40. PubMed ID: 9695994
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy.
Terjung B; Worman HJ; Herzog V; Sauerbruch T; Spengler U
Clin Exp Immunol; 2001 Oct; 126(1):37-46. PubMed ID: 11678897
[TBL] [Abstract][Full Text] [Related]
4. [Antineutrophil cytoplasmic antibodies in chronic inflammatory bowel diseases].
Schlenker T; Apenberg S; Raedsch R; Andrassy K; Plachky J; Kommerell B
Dtsch Med Wochenschr; 1992 Sep; 117(39):1463-8. PubMed ID: 1396127
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis.
Mulder L; van Rossum M; Horst G; Limburg P; de Graeff-Meeder ER; Kuis W; Kallenberg C
J Rheumatol; 1997 Mar; 24(3):568-75. PubMed ID: 9058667
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
9. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines.
Terjung B; Spengler U; Sauerbruch T; Worman HJ
Gastroenterology; 2000 Aug; 119(2):310-22. PubMed ID: 10930366
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
[TBL] [Abstract][Full Text] [Related]
11. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic aspects in the determination of antineutrophil cytoplasmic antibodies].
Manes M; Bonfant G; Belfanti P; Gaiter AM; Alloatti S
Recenti Prog Med; 1997 Jan; 88(1):17-20. PubMed ID: 9102709
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases.
Roozendaal C; Kallenberg CG
Hepatogastroenterology; 1999; 46(30):3034-40. PubMed ID: 10626156
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies (ANCA).
Radice A; Sinico RA
Autoimmunity; 2005 Feb; 38(1):93-103. PubMed ID: 15804710
[TBL] [Abstract][Full Text] [Related]
16. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease.
García Herola A; Nos P; Hinijosa J; Hoyos M; Molés JR; Carmona E; Puig N; Sánchez-Cuenca JM; Ponce J; Berenguer J
Rev Esp Enferm Dig; 2003 Nov; 95(11):760-4, 755-9. PubMed ID: 14640873
[TBL] [Abstract][Full Text] [Related]
17. p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ.
Terjung B; Söhne J; Lechtenberg B; Gottwein J; Muennich M; Herzog V; Mähler M; Sauerbruch T; Spengler U
Gut; 2010 Jun; 59(6):808-16. PubMed ID: 19951907
[TBL] [Abstract][Full Text] [Related]
18. p-ANCA target antigens in ulcerative colitis.
Folwaczny C; Jochum M; Noehl N; Schnettler D; Loeschke K; Fricke H
Z Gastroenterol; 1998 Aug; 36(8):625-33. PubMed ID: 9773480
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibodies (ANCA) in the clinical forms of leprosy.
Freire BF; Ferraz AA; Nakayama E; Ura S; Queluz TT
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):475-82. PubMed ID: 10347568
[TBL] [Abstract][Full Text] [Related]
20. Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis.
Klein R; Eisenburg J; Weber P; Seibold F; Berg PA
Hepatology; 1991 Dec; 14(6):1147-52. PubMed ID: 1720413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
